Cargando…

Comparative analysis of the labelling of nanotechnologies across four stakeholder groups

Societies are constantly challenged to develop policies around the introduction of new technologies, which by their very nature contain great uncertainty. This uncertainty gives prominence to varying viewpoints which are value laden and have the ability to drastically shift policy. The issue of nano...

Descripción completa

Detalles Bibliográficos
Autores principales: Capon, Adam, Gillespie, James, Rolfe, Margaret, Smith, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518076/
https://www.ncbi.nlm.nih.gov/pubmed/26246798
http://dx.doi.org/10.1007/s11051-015-3129-8
_version_ 1782383279099346944
author Capon, Adam
Gillespie, James
Rolfe, Margaret
Smith, Wayne
author_facet Capon, Adam
Gillespie, James
Rolfe, Margaret
Smith, Wayne
author_sort Capon, Adam
collection PubMed
description Societies are constantly challenged to develop policies around the introduction of new technologies, which by their very nature contain great uncertainty. This uncertainty gives prominence to varying viewpoints which are value laden and have the ability to drastically shift policy. The issue of nanotechnologies is a prime example. The labelling of products that contain new technologies has been one policy tool governments have used to address concerns around uncertainty. Our study develops evidence regarding opinions on the labelling of products made by nanotechnologies. We undertook a computer-assisted telephone (CATI) survey of the Australian public and those involved in nanotechnologies from the academic, business and government sectors using a standardised questionnaire. Analysis was undertaken using descriptive and logistic regression techniques. We explored reluctance to purchase as a result of labelling products which contained manufactured nanomaterials both generally and across five broad products (food, cosmetics/sunscreens, medicines, pesticides, tennis racquets/computers) which represent the broad categories of products regulated by differing government agencies in Australia. We examined the relationship between reluctance to purchase and risk perception, trust, and familiarity. We found irrespective of stakeholder, most supported the labelling of products which contained manufactured nanomaterials. Perception of risk was the main driver of reluctance to purchase, while trust and familiarity were likely to have an indirect effect through risk perception. Food is likely to be the greatest product impacted by labelling. Risk perception surrounding nanotechnologies and label ‘framing’ on the product are key issues to be addressed in the implementation of a labelling scheme.
format Online
Article
Text
id pubmed-4518076
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-45180762015-08-03 Comparative analysis of the labelling of nanotechnologies across four stakeholder groups Capon, Adam Gillespie, James Rolfe, Margaret Smith, Wayne J Nanopart Res Perspectives Societies are constantly challenged to develop policies around the introduction of new technologies, which by their very nature contain great uncertainty. This uncertainty gives prominence to varying viewpoints which are value laden and have the ability to drastically shift policy. The issue of nanotechnologies is a prime example. The labelling of products that contain new technologies has been one policy tool governments have used to address concerns around uncertainty. Our study develops evidence regarding opinions on the labelling of products made by nanotechnologies. We undertook a computer-assisted telephone (CATI) survey of the Australian public and those involved in nanotechnologies from the academic, business and government sectors using a standardised questionnaire. Analysis was undertaken using descriptive and logistic regression techniques. We explored reluctance to purchase as a result of labelling products which contained manufactured nanomaterials both generally and across five broad products (food, cosmetics/sunscreens, medicines, pesticides, tennis racquets/computers) which represent the broad categories of products regulated by differing government agencies in Australia. We examined the relationship between reluctance to purchase and risk perception, trust, and familiarity. We found irrespective of stakeholder, most supported the labelling of products which contained manufactured nanomaterials. Perception of risk was the main driver of reluctance to purchase, while trust and familiarity were likely to have an indirect effect through risk perception. Food is likely to be the greatest product impacted by labelling. Risk perception surrounding nanotechnologies and label ‘framing’ on the product are key issues to be addressed in the implementation of a labelling scheme. Springer Netherlands 2015-07-29 2015 /pmc/articles/PMC4518076/ /pubmed/26246798 http://dx.doi.org/10.1007/s11051-015-3129-8 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Perspectives
Capon, Adam
Gillespie, James
Rolfe, Margaret
Smith, Wayne
Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title_full Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title_fullStr Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title_full_unstemmed Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title_short Comparative analysis of the labelling of nanotechnologies across four stakeholder groups
title_sort comparative analysis of the labelling of nanotechnologies across four stakeholder groups
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518076/
https://www.ncbi.nlm.nih.gov/pubmed/26246798
http://dx.doi.org/10.1007/s11051-015-3129-8
work_keys_str_mv AT caponadam comparativeanalysisofthelabellingofnanotechnologiesacrossfourstakeholdergroups
AT gillespiejames comparativeanalysisofthelabellingofnanotechnologiesacrossfourstakeholdergroups
AT rolfemargaret comparativeanalysisofthelabellingofnanotechnologiesacrossfourstakeholdergroups
AT smithwayne comparativeanalysisofthelabellingofnanotechnologiesacrossfourstakeholdergroups